These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12598432)

  • 41. Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial.
    Hutton DW; Stein JD; Bressler NM; Jampol LM; Browning D; Glassman AR;
    JAMA Ophthalmol; 2017 Jun; 135(6):576-584. PubMed ID: 28492920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence of visual impairment due to cataract, diabetic retinopathy and trachoma in indigenous Australians within central Australia: the Central Australian Ocular Health Study.
    Landers J; Henderson T; Craig JE
    Clin Exp Ophthalmol; 2013; 41(1):50-5. PubMed ID: 22594763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
    Shimura M; Yasuda K; Shiono T
    Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of diabetic retinopathy, cataract and visual impairment in patients with diabetes in sub-Saharan Africa.
    Glover SJ; Burgess PI; Cohen DB; Harding SP; Hofland HW; Zijlstra EE; Allain TJ
    Br J Ophthalmol; 2012 Feb; 96(2):156-61. PubMed ID: 21515565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluating the Relationship Between Visual Acuity and Utilities in Patients With Diabetic Macular Edema Enrolled in Intravitreal Aflibercept Studies.
    Brazier J; Muston D; Konwea H; Power GS; Barzey V; Lloyd A; Sowade O; Vitti B; Gerlinger C; Roberts J
    Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4818-4825. PubMed ID: 28973328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states.
    Brown MM; Brown GC; Sharma S; Busbee B
    Ophthalmology; 2003 Jun; 110(6):1076-81. PubMed ID: 12799229
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing the impact of visual acuity on quality of life in individuals with type 2 diabetes using the short form-36.
    Clarke PM; Simon J; Cull CA; Holman RR
    Diabetes Care; 2006 Jul; 29(7):1506-11. PubMed ID: 16801570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of visual morbidity amongst diabetic retinopathy at tertiary eye care center, Nepal: a cross-sectional descriptive study.
    Pandey A; Lamichhane G; Khanal R; Rai SKC; Bhari AM; Borroni D; Gautam N
    BMC Ophthalmol; 2017 Dec; 17(1):263. PubMed ID: 29282017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetic eye disease: a natural history study.
    Taylor RH; Jones HS; Dodson PM; Hamilton AP; Kritzinger EE
    Eye (Lond); 1997; 11 ( Pt 4)():547-53. PubMed ID: 9425422
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relationship between visual acuity and functioning and well-being among diabetics.
    Lee PP; Whitcup SM; Hays RD; Spritzer K; Javitt J
    Qual Life Res; 1995 Aug; 4(4):319-23. PubMed ID: 7550180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is utility-based quality of life in adults affected by glaucoma?
    Gothwal VK; Bagga DK; Rao HL; Bharani S; Sumalini R; Garudadri CS; Senthil S; Reddy SP; Pathak-Ray V; Mandal AK
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1361-9. PubMed ID: 24519425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Health-related quality of life--using the 15D instrument--of young adults with type 1 diabetes since childhood. Population-based Oulu cohort study of diabetic retinopathy.
    Hannula V; Hautala N; Sintonen H; Falck A
    Acta Ophthalmol; 2014 May; 92(3):205-8. PubMed ID: 23763986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.
    ; Aiello LP; Davis MD; Girach A; Kles KA; Milton RC; Sheetz MJ; Vignati L; Zhi XE
    Ophthalmology; 2006 Dec; 113(12):2221-30. PubMed ID: 16989901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact on utilities of differences in body weight among Canadian patients with type 2 diabetes.
    Lane S; Levy AR; Mukherjee J; Sambrook J; Tildesley H
    Curr Med Res Opin; 2014 Jul; 30(7):1267-73. PubMed ID: 24588550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychological, social and everyday visual impact of diabetic macular oedema and diabetic retinopathy: a systematic review.
    Cooper OAE; Taylor DJ; Crabb DP; Sim DA; McBain H
    Diabet Med; 2020 Jun; 37(6):924-933. PubMed ID: 31479552
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychometric development of the individualized Retinopathy-Dependent Quality of Life Questionnaire (RetDQoL).
    Brose LS; Bradley C
    Value Health; 2010; 13(1):119-27. PubMed ID: 19695003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diabetic retinopathy and health-related quality of life.
    Davidov E; Breitscheidel L; Clouth J; Reips M; Happich M
    Graefes Arch Clin Exp Ophthalmol; 2009 Feb; 247(2):267-72. PubMed ID: 18925408
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of colour vision as a screening test for sight threatening diabetic retinopathy before loss of vision.
    Ong GL; Ripley LG; Newsom RS; Casswell AG
    Br J Ophthalmol; 2003 Jun; 87(6):747-52. PubMed ID: 12770974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vision utilities in Italy and the United States: Comparison of time tradeoff vision utilities.
    De Salvo G; Brown GC; Brown MM
    Eur J Ophthalmol; 2020 Mar; 30(2):253-257. PubMed ID: 30696257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pattern of diabetic retinopathy in Kano, Nigeria.
    Lawan A; Mohammed TB
    Ann Afr Med; 2012; 11(2):75-9. PubMed ID: 22406665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.